Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease

NCT06600490

Conditions
Behavior, Behavior and Behavior Mechanisms, Infections, +7 more
Locations
  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hellerup, Capital Region, Denmark
View Trial Details
Completed

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults

NCT05517174

Conditions
Infections, Influenza, Influenza, Human, +7 more
Locations
  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hellerup, Capital Region, Denmark
  • Danske Lægers Vaccinations Service Søborg, Denmark
View Trial Details
Completed

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

NCT04969276

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number :8400003 Glendale, Arizona, United States
  • Investigational Site Number :8400006 San Diego, California, United States
  • Investigational Site Number :8400004 Vista, California, United States
  • Investigational Site Number :8400005 Centennial, Colorado, United States
View Trial Details
Completed

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

NCT05829356

Conditions
Infections, Influenza Immunization, Influenza, Human, +5 more
Locations
  • Investigational Site Number : 0360004 Herston, Queensland, Australia
  • Investigational Site Number : 0360001 Morayfield, Queensland, Australia
  • Investigational Site Number : 0360002 Camberwell, Victoria, Australia
  • Investigational Site Number : 0360003 Adelaide, Australia
View Trial Details
Completed

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

NCT05144945

Conditions
Infections, Influenza (Healthy Volunteers), Influenza, Human, +5 more
Locations
  • Investigational Site Number :4100003 Ansan-si, Gyeonggi-do, South Korea
  • Investigational Site Number :4100001 Seoul, Seoul-teukbyeolsi, South Korea
  • Investigational Site Number :4100002 Seoul, South Korea
View Trial Details
Completed

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

NCT01773928

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • East Valley Family Physicians, PLC Chandler, Arizona, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • Center for Clinical Trials, LLC Paramount, California, United States
  • California Research Foundation San Diego, California, United States
View all 20 locations
View Trial Details
Completed

Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

NCT06507553

Conditions
Healthy Volunteers, Infections, Influenza, +6 more
Locations
  • Investigational Site Number : 0360002 Botany, New South Wales, Australia
  • Investigational Site Number : 0360010 Brookvale, New South Wales, Australia
  • Investigational Site Number : 0360012 Maroubra, New South Wales, Australia
  • Investigational Site Number : 0360011 Miranda, New South Wales, Australia
View Trial Details

Related conditions